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Abstract
SAMHD1 is a host restriction factor that blocks the ability of lentiviruses such as HIV-1 to undergo reverse transcription in
myeloid cells and resting T-cells. This restriction is alleviated by expression of the lentiviral accessory proteins Vpx and Vpr
(Vpx/Vpr), which target SAMHD1 for proteasome-mediated degradation. However, the precise determinants within
SAMHD1 for recognition by Vpx/Vpr remain unclear. Here we show that evolution of Vpx/Vpr in primate lentiviruses has
caused the interface between SAMHD1 and Vpx/Vpr to alter during primate lentiviral evolution. Using multiple HIV-2 and
SIV Vpx proteins, we show that Vpx from the HIV-2 and SIVmac lineage, but not Vpx from the SIVmnd2 and SIVrcm lineage,
require the C-terminus of SAMHD1 for interaction, ubiquitylation, and degradation. On the other hand, the N-terminus of
SAMHD1 governs interactions with Vpx from SIVmnd2 and SIVrcm, but has little effect on Vpx from HIV-2 and SIVmac.
Furthermore, we show here that this difference in SAMHD1 recognition is evolutionarily dynamic, with the importance of
the N- and C-terminus for interaction of SAMHD1 with Vpx and Vpr toggling during lentiviral evolution. We present a model
to explain how the head-to-tail conformation of SAMHD1 proteins favors toggling of the interaction sites by Vpx/Vpr during
this virus-host arms race. Such drastic functional divergence within a lentiviral protein highlights a novel plasticity in the
evolutionary dynamics of viral antagonists for restriction factors during lentiviral adaptation to its hosts.
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Introduction
HIV-1, HIV-2, and other primate lentiviruses encode accessory
virulence factors that serve to enhance viral infectivity. This is
largely achieved through increasing virus replication by counter-
acting host antiviral proteins, known as restriction factors [1]. One
such restriction factor, SAMHD1, is a deoxynucleoside triphos-
phate triphosphohydrolase that suppresses cellular dNTP pools
[2,3]. This prevents efficient infection of monocytes, dendritic cells
(DCs), and mature macrophages by reducing the dNTP pools
below the levels needed for reverse transcription of viral RNA
[4,5]. SAMHD1 has also been shown to contribute to the
restriction of HIV-1 infection in resting T cells [6,7]. SAMHD1 is
composed of two structural domains: a sterile alpha motif (SAM)
domain, responsible for protein-protein interactions, and a
histidine-aspartic (HD) domain, responsible for the phosphohy-
drolase activity of the protein.
Vpx is a primate lentiviral accessory protein that antagonizes
SAMHD1 function by targeting it for proteasome-mediated
degradation [8,9]. Supplying Vpx in trans to HIV-1 infected
monocytes, DCs, macrophages, or resting T-cells alleviates the
SAMHD1-mediated block of efficient reverse transcription,
resulting in productive infection [6,8,9]. Vpx achieves this by
directly binding to SAMHD1 and simultaneously to the DCAF1
substrate receptor of the CRL4 E3 ubiquitin ligase (CRL4DCAF1),
thereby loading SAMHD1 onto this E3 complex for polyubiqui-
tylation and subsequent degradation [8,10]. The CRL4DCAF1 E3
complex usurped by Vpx consists of DCAF1, DDB1, CUL4 and
RBX1 [8–12]. While SAMHD1 alone is unable to interact with
DCAF1, Vpx bridges this interaction [8,10], in such accelerating
SAMHD1 protein turnover.
Despite its important role in lentivirus infectivity [13], Vpx is
found in only two of the eight major lineages of primate
lentiviruses: those of the SIVsmm/SIVmac/HIV-2 (Simian
Immunodeficiency Virus of sooty mangabey, rhesus macaque,
and Human Immunodeficiency Virus 2, respectively) and
SIVrcm/mnd2 (Red Capped Mangabey and Mandrill viruses,
respectively) lineages [14,15]. In contrast, all extant primate
lentiviruses encode for Vpr, a paralog of Vpx, which has primarily
been shown to cause G2 arrest of infected cells [16–19]. Beyond
their homology, Vpx and Vpr share functional similarities; namely
they are both presumed to target host restriction factor(s) for
degradation through their interaction with the CRL4DCAF1
complex (reviewed in [20]). Previously we showed that a subset
of Vpr proteins from lentiviruses lacking Vpx are also able to
degrade their host SAMHD1, and that this activity arose prior to
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the genesis of Vpx through recombination/duplication [21]. This
indicates that the conflict between Vpx/Vpr and host SAMHD1
has been ongoing for much of primate lentiviral evolution.
One defining characteristic of restriction factors is their
engagement in an evolutionary arms-race with the viruses that
they inhibit [22–24]. This evolutionary dynamic can be identified
as a signature of positive selection on host genes, such that codons
accumulate mutations that result in amino acid changes at a
higher frequency than expected by neutral drift. Due to the strong
selective pressure imposed directly by the virus, amino acids
important for the interaction between the restriction factor and its
viral antagonist are often the same residues displaying the
strongest signatures of positive selection [21,24–26]. Indeed,
SAMHD1 has undergone bursts of positive selection in the
Cercopithecinae branch of Old World monkeys (OWM), and the
amino acids in the N-terminal SAM domain of SAMHD1 that
show the most significant signatures of positive selection are
directly involved in the species-specific interaction of SAMHD1
with SIVmnd2 Vpx and SIVagm Vpr [21]. On the other hand,
when the evolution of SAMHD1 is analyzed through a broader
window of primates (including prosimians and New World
monkeys) residues in the C-terminus of SAMHD1 are also found
to be evolving under positive selection [27]. Furthermore, it has
been shown that the C-terminus of SAMHD1 is critical for
binding and degradation of SAMHD1 by Vpx from HIV-2 and
SIVmac [10,27,28]. Thus, there is an apparent discrepancy
between the sites of positive selection in SAMHD1 in OWM,
where most of the primate lentiviruses exist, and the specificity of
Vpx.
Here we resolve the complex specificity of Vpx/Vpr for
SAMHD1 by showing that different orthologs of Vpx/Vpr have
evolved multiple distinct means to target SAMHD1. While some
Vpx proteins (those of HIV-2 and SIVmac) require the C-terminus
of SAMHD1 for recognition, binding, ubiquitylation, and
ultimately degradation of this host restriction factor, others (those
of SIVmnd2 and SIVrcm) recognize the N-terminus of SAMHD1.
Furthermore, by analyzing more diverse Vpr proteins, we found
that this recognition is evolutionarily dynamic, with both N- and
C-terminal recognition arising throughout Vpx and Vpr evolution.
Thus, this viral antagonist has the capacity to evolve distinct
specificities for its host target. We present a model to explain this
unique phenomenon based on the head-to-tail orientation of
SAMHD1 tetramers. This drastic functional divergence within a
lentiviral protein highlights a novel plasticity in the evolutionary
dynamics of viral antagonists for restriction factors during
lentiviral cross-species transmission and adaptation to a new host.
Results
Different recognition of SAMHD1 by divergent Vpx
proteins
The finding that amino acids in the N-terminus of SAMHD1
confer the specificity of SIVmnd2 Vpx and SIVagm Vpr for
SAMHD1 [21], yet HIV-2 and SIVmac Vpx require the C-
terminus of SAMHD1 for binding and degradation [10,27,28],
suggested a certain complexity to the modes of SAMHD1
recognition by Vpx/Vpr. We hypothesized that different Vpx/
Vpr proteins have evolved to interact with different surfaces of
SAMHD1. In fact, although Vpx/Vpr proteins are related at the
sequence level, phylogenetic analysis shows that there are two
distinct Vpx clades that interact with SAMHD1, one containing
HIV-2 and SIVmac, and another containing SIVmnd2 and
SIVrcm [21] (summarized in Figure 1A). In addition, Vpr from
some, but not all primate lentiviruses can degrade SAMHD1 [21]
(Figure 1A). In order to assess how distinct Vpx and Vpr proteins
recognize SAMHD1, we generated a set of SAMHD1 constructs,
either truncated at the C-terminus or chimeric at the N-terminus,
and assayed for the ability of multiple Vpx/Vpr proteins to
degrade these SAMHD1 proteins. Chimeras and truncations were
based on previous results which showed that SAMHD1 is still
catalytically active and able to form tetramers when truncated at
the C-terminus or the N-terminus [29].
First, we looked at the dependence of Vpx on the C-terminus of
SAMHD1. Previous results have shown that truncation of the last
15 amino acids of human SAMHD1 abrogated the interaction of
SIVmac and HIV-2 Vpx with SAMHD1 [10,27]. To test for
degradation of a C-terminally truncated version of SAMHD1 (DC
SAMHD1, truncated from amino acid 612–626) (Figure 1B), we
co-transfected human 293T cells with FLAG-tagged Vpx and HA-
tagged SAMHD1, and assayed for a decrease of SAMHD1
expression. We initially tested HIV-2 Vpx, SIVmac Vpx,
SIVmnd2 Vpx and SIVrcm Vpx for their ability to degrade their
own host species SAMHD1. As expected, each Vpx tested was
able to degrade its autologous host SAMHD1 (Figure 1C).
However, while HIV-2 and SIVmac Vpx were unable to degrade
SAMHD1 truncated at the C-terminus (Figure 1C, left panel),
neither SIVmnd2 nor SIVrcm Vpx required the C-terminus of
SAMHD1 for degradation, as both Vpx proteins were readily able
to degrade WT and DC constructs (Figure 1C, right panel). This
suggests that these Vpx proteins evolved differences in their
specificity determinants for degradation of SAMHD1, possibly due
to the selective pressure on SAMHD1. We also assayed a panel of
phylogenetically distinct HIV-2 Vpx genes representing clades A,
B, and H as well as Vpx from SIVsmm (Figure S1A) for
degradation of WT and DC human SAMHD1. We found that
while all but one of the Vpx tested could degrade full-length
SAMHD1, none was able to degrade the DC construct (Figure
S1B). This suggests that the dependence on the C-terminus of
SAMHD1 is indeed conserved within the diversity of HIV-2 Vpx
and its precursor SIVsmm Vpx, but is different from the
requirements of SIVmnd2 and SIVrcm Vpx to degrade
SAMHD1.
Because we have previously shown that amino acids under
positive selection in the N-terminus of SAMHD1 affect binding
and degradation by SIVmnd2 Vpx [21], we next tested the effects
Author Summary
At least 40 primate species in the wild are infected with
their own lentivirus. Many of these infections arose from
cross-species transmission followed by adaptation to a
new host. Host antiviral proteins, called restriction factors,
work to defend against both known and novel viruses and
are thus engaged in a constant arms race with viral
proteins. SAMHD1 is a restriction factor that blocks
lentiviral infection of certain immune cells. However,
SAMHD1 is counteracted by the lentiviral proteins Vpx
and Vpr. Here we show that both Vpx and Vpr have
evolved to recognize distinct interfaces of SAMHD1,
consistent with the idea that SAMHD1 is rapidly evolving
to evade this recognition. Furthermore, we show that
while the site of this antagonism has been changing back
and forth throughout lentiviral evolution, the mechanism
by which Vpx and Vpr antagonize SAMHD1 has remained
constant. These data illustrate a novel phenomenon in
which there is an evolutionary toggling of divergent
recognition between a restriction factor and its viral
antagonist.
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of natural variation in the N-terminus of SAMHD1 on Vpx-
mediated degradation by diverse Vpx proteins. We therefore
generated SAMHD1 chimeras by swapping the first 114 amino
acids (including the N-terminus and the SAM domain) of human
SAMHD1 with those of either mandrill or RCM SAMHD1
(Figure 2A). Human SAMHD1 was used for these chimeras
Figure 1. HIV-2 and SIVmac Vpx require the C-terminus of SAMHD1 for degradation. (A) Schematic Vpx/Vpr phylogenetic tree based on
[21] of select lentiviral Vpx and Vpr proteins that degrade SAMHD1. (B) Schematic representation of SAMHD1 (WT) and C-terminal truncation (DC),
including the SAM and HD domains shown in grey. The deletion at the C-terminus of SAMHD1 (green dotted line) truncates the protein at amino acid
611. Amino acid numbers are shown to indicate the relative boundaries of the domains. (C) 293T cells were transfected with HA-SAMHD1, either WT
or DC (green), plus or minus (2) FLAG-Vpx from autologous viruses, and degradation was measured by western blotting. SAMHD1 levels are shown
on the top blot, Vpx levels are shown in the middle blot, and tubulin levels are shown in the bottom blot (as a loading control). Note the differences
between degradation of the WT SAMHD1 versus the DC SAMHD1 in the presence of some Vpx proteins, but not others.
doi:10.1371/journal.ppat.1003496.g001
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because it is quite divergent at the N-terminus with 12 or 13 amino
acids that differ relative to mandrill or RCM, respectively, three of
which show strong signatures of positive selection (Figure 2A and
Figure S2). Notably, neither SIVmnd2 Vpx (Figure 2B, top panels)
nor SIVrcm Vpx (Figure 2B, lower panels) were able to degrade
human SAMHD1, while HIV-2 Vpx was able to degrade both
Figure 2. SIVmnd2 and SIVrcm Vpx require the N-terminus of SAMHD1 for degradation. (A) Schematic representation of WT SAMHD1
and chimeric proteins. Amino acids in the N-terminus that differ between human (Hu) SAMHD1 and mandrill (Mnd) or RCM SAMHD1 are shown as
tick-marks, while codons that differ and have been shown to be evolving under strong positive selection (amino acids 32, 36, and 107) are shown
with arrowheads. The regions of the chimeric SAMHD1 protein coming from the human gene are shown in purple, while the regions coming from
mandrill or RCM SAMHD1 are shown in grey. (B) 293T cells were transfected with HA-tagged WT or chimeric SAMHD1, plus or minus (2) FLAG-Vpx,
and degradation was measured by western blotting as described in the legend for Figure 1.
doi:10.1371/journal.ppat.1003496.g002
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mandrill and RCM SAMHD1. Importantly, when we replaced
the first 114 residues of mandrill or RCM SAMHD1 with that of
human, neither SIVmnd2 nor SIVrcm Vpx were able to degrade
these chimeric SAMHD1 proteins. However, both SIVmnd2 Vpx
and SIVrcm Vpx (as well as HIV-2 Vpx) were able to degrade the
respective reciprocal SAMHD1 chimeras, where either mandrill
or RCM N-terminus was fused with the rest of human SAMHD1
(Figure 2B). Thus, the N-terminus of mandrill and RCM
SAMHD1 are sufficient to confer degradation of human
SAMHD1 by SIVmnd2 and SIVrcm Vpx, respectively. These
results demonstrate that while SIVmnd2 and SIVrcm are
insensitive to truncations at the C-terminus of SAMHD1
(Figure 1C), the species-specific sequence differences within the
N-terminus of SAMHD1 are necessary and sufficient for
degradation by SIVmnd2 and SIVrcm Vpx. On the other hand,
HIV-2 Vpx (and SIVmac Vpx, data not shown), which depends
on the C-terminus of SAMHD1 for degradation (Figure 1C), is not
affected by the natural sequence variation present in the N-
terminus of mandrill or RCM SAMHD1 (Figure 2).
We also wanted to determine if a Vpx shows the same
requirement for either the C-terminus or changes in the N-
terminus regardless of the SAMHD1 it is challenged with.
Therefore, we assayed for the ability of the divergent SIVmac or
SIVmnd2 Vpx to degrade multiple species’ SAMHD1, either C-
terminal deleted or chimeric at the N-terminus (Figure 3). Similar
to the results with the autologous SAMHD1, we found that
SIVmnd2 Vpx degrades both wild type and DC SAMHD1 from
rhesus, mandrill, and RCM, while SIVmac was unable to degrade
DC SAMHD1 from any of the four species, though it was able to
degrade the wild type protein from all (Figure 3A). Conversely,
when SIVmac Vpx was assayed against chimeric SAMHD1
constructs (Figure 3B), it was able to degrade all four constructs,
regardless of the sequence at the N-terminus. However, SIVmnd2
Vpx was unable to degrade those with human N-termini
(Figure 3B). Together, these data indicate that Vpx from distinct
viral lineages have evolved different requirements for degradation
of SAMHD1 and that these requirements are intrinsic to Vpx.
Vpx degrades SAMHD1 through a conserved mechanism,
despite N- or C-terminal binding
SIVmac Vpx has been shown to target human SAMHD1 for
proteasome-mediated degradation by interacting directly with
SAMHD1 as well as the E3 ubiquitin ligase complex consisting of
DCAF1, DDB1, and CUL4-RBX1 [10]. However, with such
disparate requirements for SAMHD1 degradation between
SIVmac and SIVmnd2/SIVrcm Vpx, we asked if the N-terminal
binding SIVmnd2 and SIVrcm Vpx proteins utilize the same
DCAF1 substrate receptor and E3 complex as the C-terminal
binding SIVmac Vpx. We assayed for interaction of SAMHD1
with Vpx and endogenous DCAF1 and DDB1 via co-immuno-
precipitations (co-IP) in 293T cells (Figure 4). The presence of
DCAF1 and DDB1 in the co-IP represents formation of a
CRL4DCAF1 complex that includes SAMHD1 and Vpx. We found
that, similar to human and rhesus SAMHD1, full-length mandrill
and RCM SAMHD1 interact with Vpx from their autologous
virus, as well as the ubiquitin ligase components DCAF1 and
DDB1 (Figure 4B, WT SAMHD1 lanes). Consistent with previous
results [10], we found that SAMHD1 does not interact with DDB1
and/or DCAF1 in the absence of Vpx (Figure S3B and S3C).
Thus, formation of the CRL4DCAF1 complex is conserved between
Vpx proteins, regardless of whether the Vpx protein utilizes the N-
or C-terminus of SAMHD1 for binding.
These results allowed us to next ask whether the failure to
degrade either N- or C-terminally truncated SAMHD1 is due to
the inability of Vpx proteins to recruit the mutant SAMHD1
proteins to the E3 complex. We performed co-IP analyses of both
C-terminally truncated (DC) and N-terminally truncated (DN)
SAMHD1 (Figure 4A) in 293T cells, and assayed for interaction
with Vpx, DCAF1 and DDB1 (Figure 4B). In agreement with the
degradation profiles, both human and rhesus DC SAMHD1 were
unable to bind to their autologous Vpx and consequently to DDB1
and DCAF1 (Figure 4B, left panel), while the DN truncations show
a less dramatic effect on binding. Conversely, truncating mandrill
or RCM SAMHD1 at the C-terminus had no effect on Vpx,
DDB1, or DCAF interaction, yet DN SAMHD1 truncations
completely blocked these interactions. These data were further
confirmed through gel filtration size exclusion chromatography of
SAMHD1-Vpx-DDB1-DCAF1c complexes formed with purified
recombinant proteins in vitro (Figure S3), such that SIVmac Vpx
was able to recruit WT and DN SAMHD1 to a DDB1-DCAF1c
complex, but not DC SAMHD1 (Figure S3D; controls without
Vpx-DDB1-DCAF1c, without SAMHD1, and without Vpx in
Figure S3A, B, and C, respectively). On the other hand, SIVrcm
Vpx was unable to recruit a DN SAMHD1 from rhesus, yet it was
readily able to interact with WT and DC rhesus SAMHD1 (Figure
S3E). In agreement with the degradation data, these data suggest
that the inability of Vpx to degrade SAMHD1 is due to an
inability to recruit SAMHD1 to the DCAF1 subunit of the E3
complex. Furthermore, regardless of the precise requirement for
SAMHD1 binding, all Vpx tested can utilize the same
CRL4DCAF1 E3 ubiquitin ligase to antagonize SAMHD1.
Finally, to show that these interactions result in the ubiquitin-
mediated degradation of SAMHD1, we performed an in vitro
ubiquitylation assay [10]. We found that when WT, DC, or DN
rhesus SAMHD1 was incubated with a preformed Cul4-DCAF1c-
VpxSIVmac E3 ubiquitin ligase complex, WT and DN SAMHD1
were readily ubiquitylated in the presence of Vpx, however DC
SAMHD1 was not (Figure 4C, left panel). Conversely, when these
SAMHD1 proteins were incubated with CRL4-DCAF1c-
VpxSIVrcm, WT and DC SAMHD1 were ubiquitylated, however
DN SAMHD1 was not (Figure 4C, right panel). This is in
agreement with our previous data and demonstrates a conserved
pathway of ubiquitin-mediated degradation despite different N-
and C-terminal SAMHD1 binding by different Vpx proteins.
SIVrcm Vpx utilizes a distinct interface to recognize
SAMHD1
Our data showing that all Vpx-SAMHD1 complexes bind
DCAF1 and the DDB1 module of CRL4DCAF1 suggests that the
region of Vpx that binds this E3 ubiquitin ligase complex has been
conserved throughout lentiviral evolution. However, our observa-
tion that different Vpx proteins bind distinct regions of SAMHD1
raised the possibility that the Vpx surface utilized to bind
SAMHD1 has changed during primate lentiviral evolution. Thus,
we wanted to investigate if N-terminal binding Vpx proteins
require the same residues in Vpx to degrade SAMHD1 as C-
terminal binding Vpx proteins.
It has been previously shown that amino acids 12, 15, 16, and
17 are necessary for the ability of C-terminally binding SIVmac
Vpx to interact with human SAMHD1 in order to load it onto
DCAF1 for degradation [10] and to subsequently allow for viral
infectivity in macrophage and dendritic cells [30]. However, the
amino acids at positions 12, 15, 16, and 17 in SIVmnd2 and
SIVrcm Vpx differ from those of HIV-2 and SIVmac Vpx
(Figure 5A), suggesting the possibility that differences in this region
may be important for N- and C-terminal recognition. Therefore,
we attempted to change the specificity of these Vpx proteins for
the N- or the C-terminus by swapping amino acids 12/15/16/17
Evolution Toggling of Vpx/Vpr-SAMHD1 Recognition
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in SIVmnd2 and SIVrcm to those of HIV-2 Vpx and SIVmac
Vpx, as well as the reciprocal change of HIV-2 Vpx and SIVmac
Vpx to those of SIVmnd2 and SIVrcm. Changing these residues in
both HIV-2 and SIVmac Vpx abolished the activity of these
proteins against their host SAMHD1 (Figure 5B), indicating that
the precise residues are necessary for HIV-2 and SIVmac Vpx to
degrade SAMHD1. These changes also rendered SIVmnd2 Vpx
unable to degrade mandrill SAMHD1 (Figure 5B), suggesting that
though the specific residues differ between HIV-2/SIVmac and
SIVmnd2 Vpx, the precise residues at this position are also
required for recognition of SAMHD1 by SIVmnd2 Vpx.
Interestingly, a SIVrcm Vpx mutant at these positions was still
able to degrade RCM SAMHD1, although with slightly decreased
activity (Figure 5B). Importantly, these amino acid changes did not
change the specificity of SIVrcm Vpx for the N-terminus of
SAMHD1 versus the C-terminus of SAMHD1 (Figure S4).
Nonetheless, these data suggest that SIVrcm Vpx utilizes a distinct
interface to bind to RCM SAMHD1 for recruitment to the
CRL4DCAF1 E3 complex.
Evolutionary ‘‘toggling’’ of Vpx/Vpr specificity towards
SAMHD1
Our previously published data suggests that the ability of Vpx to
degrade SAMHD1 arose first in Vpr, prior to the duplication/
recombination event that led to the genesis and subsequent
subfunctionalization of Vpx [21]. Given our results that SAMHD1
recognition is distinct between different Vpx lineages, we wished to
determine how the specificity for SAMHD1 evolved in Vpr proteins
that arose prior to the Vpx duplication (e.g. SIVdeb, SIVsyk, and
SIVmus Vpr, Figure 1A). We found that SIVsyk and SIVmus Vpr,
like HIV-2 and SIVmac Vpx, were unable to degrade a rhesus
SAMHD1 that was truncated at the C-terminus (Figure 6A, left
panels), suggesting a C-terminal dependence. We further assayed
for the dependence on natural variation at the N-terminus of
SAMHD1 by testing each Vpr for their ability to degrade human
SAMHD1 and a chimeric rhesus SAMHD1 with human SAMHD1
N-terminus (schematic as in Figure 2A). We found that SIVsyk Vpr
cannot degrade human SAMHD1, but can degrade the rhesus
SAMHD1 chimera with a human N-terminus (Figure 6A, right
Figure 3. Vpx specificity for N- versus C-terminal binding of SAMHD1 is independent of the SAMHD1 homologue. (A) Empty vector
control, C-terminal binding FLAG-SIVmac Vpx, or N-terminal binding FLAG-SIVmnd2 Vpx were co-transfected in 293T cells with HA-SAMHD1, either
WT or DC, from multiple primate species, and degradation of SAMHD1 was measured by western blotting. (B) Same as in (A) except chimeric
SAMHD1 proteins were used instead of WT or DC.
doi:10.1371/journal.ppat.1003496.g003
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Figure 4. N- and C-terminal binding Vpx proteins degrade SAMHD1 through a conserved mechanism. (A) Schematic representation of
wild type (WT) SAMHD1, C-terminally truncated SAMHD1 (DC, shown in green), and N-terminally truncated SAMHD1 (DN, shown in blue). Amino acid
numbers of the truncations are shown, with dotted line indicating the truncated region of SAMHD1. (B) HA-SAMHD1 (WT, DC, and DN) were
transiently co-expressed in 293T cells with the autologous FLAG-Vpx and immunoprecipitated from whole cell extracts with anti-HA resin. HA-
SAMHD1, FLAG-Vpx, DCAF, and DDB1 were detected in immune complexes (top panels) or extracts (bottom panels) by western blotting. * denotes
the antibody light-chain. (C) In vitro ubiquitylation of WT, DC, and DN rhesus SAMHD1, in the presence or absence of SIVmac Vpx (left panel) or
SIVrcm Vpx (right panel). SAMHD1 and Vpx were incubated with Cul4, DCAF1c, RBX1, UBA1 (an E1 enzyme), UbcH5b (an E2 enzyme) and FLAG-
tagged ubiquitin for increasing time (0, 15, 30 min), and ubiquitylation of each SAMHD1 construct was analyzed by western blotting.
doi:10.1371/journal.ppat.1003496.g004
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panels). This indicates that determinants for SIVsyk Vpr are not at
the N-terminus of SAMHD1, and is consistent with the inability of
SIVsyk Vpr to degrade C-terminally truncated SAMHD1
(Figure 6A, left panels). SIVmusVpr is able to degrade both human
SAMHD1 and the human-rhesus chimeric SAMHD1, which
further suggests that SIVmus Vpr is not affected by natural
variation in the N-terminus (Figure 6A, right panels). These results
suggest that both SIVmus and SIVsyk Vpr depend primarily on the
C-terminus of SAMHD1 for degradation.
SIVdeb Vpr is interesting because its ability to degrade
SAMHD1 is not affected by truncation of the C-terminus of
SAMHD1 (Figure 6A, left panels), yet it is also not affected by
natural variation of human SAMHD1 at the N-terminus either
(Figure 6A, right panels). This result is consistent with the previous
finding that SIVdeb Vpr can degrade SAMHD1 from all primate
species tested [21], and suggests that determinants at the N- and
C-terminus are partially redundant for recognition by SIVdeb
Vpr. SIVagm.gGri Vpr also appears to involve interactions at both
N- and C- termini (Figure S5).
To directly test the specificity of SIVdeb Vpr for SAMHD1, we
used purified recombinant proteins to assay for the ability of
SIVdeb Vpr to in vitro ubiquitylate DeBrazza’s SAMHD1 lacking
the N-terminus, the C-terminus, or both the N- and C-termini
(DN/DC SAMHD1, Figure 6B). Consistent with our degradation
and interaction results, SIVdeb Vpr is able to polyubiquitylate
both DC and DN SAMHD1, although both were reduced relative
to WT SAMHD1. Interestingly, SIVdeb Vpr is still able to
polyubiquitylate DN/DC SAMHD1, though less efficiently than
DC or DN SAMHD1. This is in contrast to SIVmac which cannot
catalyze the polyubiquitylation of DC or DN/DC SAMHD1, and
SIVrcm Vpx which cannot catalyze the polyubiquitylation of DN
or DN/DC SAMHD1 (Figure 6B). These data suggest that in
addition to contributions of both the N- and the C-terminus,
SIVdeb Vpr could have evolved to further recognize the central
portion of SAMHD1 for binding and degradation. Together, these
data argue that the Vpx/Vpr-SAMHD1 interface is a dynamic
interface whose requirements for binding and degradation have
toggled back and forth through the evolution of this virus-host
arms-race (summarized in Figure 6C).
Discussion
We show that distinct Vpx/Vpr proteins require disparate
termini of SAMHD1 in order to antagonize this host restriction
Figure 5. SIVrcm Vpx utilizes a unique interface to degrade SAMHD1. (A) Alignment of the amino acids in Vpx that have been previously
shown to be important for SIVmac Vpx-mediated degradation of SAMHD1, highlighted in in black with amino acid numbers above. (B) Wild type and
mutant Vpx constructs were tested for their ability to degrade SAMHD1 by cotransfection in 293T cells, and analyzed by western blotting. HIV-212 Mnd
17 and Mac12 Mnd 17 (or HIV-212 RCM 17 and Mac12 RCM 17) indicates the amino acids 12 through 17 of HIV-2 Vpx and SIVmac Vpx that have been
changed to the corresponding amino acids found in SIVmnd2 Vpx (or SIVrcm Vpx), while RCM12 HIV-2 17 and Mnd212 HIV-2 17 indicates that amino acids
12 through 17 of SIVrcm and SIVmnd2 Vpx have been changed to the corresponding amino acids found in HIV-2/SIVmac Vpx. – indicates no Vpx
empty vector control.
doi:10.1371/journal.ppat.1003496.g005
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Figure 6. Vpx and Vpr have toggled throughout evolution in their requirement for the N- or the C-terminus of SAMHD1. (A) 293T
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factor. These differences correlate with the phylogenetic separa-
tion of Vpx, with the SIVsmm/SIVmac/HIV-2 Vpx proteins
requiring the C-terminus of SAMHD1, while the SIVmnd2/
SIVrcm Vpx proteins require the N-terminus of SAMHD1 for
binding, ubiquitylation, and subsequent degradation. Thus,
despite a conserved mechanism of degradation, Vpx from distinct
lineages of SIV show both phylogenetic and functional disparity.
Most surprisingly, the specific requirements in SAMHD1 for
degradation/binding have toggled back and forth during Vpx/
Vpr evolution in primate lentiviruses. These results demonstrate
that the antagonism between Vpx/Vpr and SAMHD1 is
evolutionarily dynamic, with virus and host sides evolving to
counteract each other through an evolvable interface.
A model to explain evolutionary toggling of the Vpx/Vpr
interaction with SAMHD1
The arms-race between antiviral host proteins and viral
antagonists often depends on sequence variation at a single
interface between virus and host proteins that results in a rapid
evolution at the point of contact [24,31]. Our results with Vpx/
Vpr and SAMHD1 indicate that more complex evolutionary
scenarios can exist in which the mode of recognition between the
viral antagonist and host protein can change. While it is possible
that recognition of the N- or the C-terminus of SAMHD1 by
Vpx/Vpr arose independent of each other, an attractive
alternative is that Vpx/Vpr can sample both the N- and the C-
terminus of SAMHD1 for optimal binding. This hypothesis is
supported by biochemical studies of SAMHD1, which show that
these termini of SAMHD1 are likely proximal in three-
dimensional space. SAMHD1 was recently crystalized as a head-
to-tail dimer [2], and further biochemical evidence indicates that
tetramerization of SAMHD1 is necessary for the phosphohydro-
lase activity of the protein [29]. Thus the proximity of the
SAMHD1 N- and C-terminus could allow Vpx/Vpr to shift its
binding from one terminus to the other (Figure 7). In this model
we suggest that both N- and C-terminal domains in SAMHD1
contribute to overall binding, but that one or the other shows
stronger affinity depending on which Vpx/Vpr protein is binding
(Figure 7A). Evolutionary pressure to evade this antagonism would
create escape mutations in SAMHD1 that would destabilize the
interaction with Vpx/Vpr (Figure 7B). However, new Vpx/Vpr
variants that re-establish the interaction with SAMHD1 could do
so by strengthening the interaction at either the N-terminus or the
C-terminus of SAMHD1 (Figure 7C). Thus giving rise to the
evolutionary toggling of Vpx/Vpr specificity for SAMHD1.
The model proposed in Figure 7 would hypothesize that some
Vpx/Vpr proteins are dependent on both N- and C-terminal
sequences for binding and degradation. Indeed, our data on
SIVdeb Vpr further supports this hypothesis, as SIVdeb Vpr
degradation of SAMHD1 is unaffected by truncations at the C-
terminus and occurs independent of variation in the N-terminus.
Furthermore, SIVdeb Vpr can polyubiquitylate both N- and C-
terminal truncations of SAMHD1, though to a lesser extent then
WT (Figure 6). Together, the identification of Vpr proteins that
show requirements for multiple domains in SAMHD1 additionally
supports our hypothesis that different affinities to either the N- or
the C-terminus are what drive the toggling of Vpx/Vpr specificity
for SAMHD1.
Differences and similarities with other lentivirus-host
arms-races
This evolutionary interaction of Vpx/Vpr with SAMHD1
differs from previously described arms-races between virus and
host factors, where the escape and re-establishment of interaction
takes place at a discrete interface [31]. For example, the
PRYSPRY domain of the antiviral factorTRIM5a is highly
variable between primate species [26], and this variation governs
the functional recognition of retroviral capsid [32]. Moreover,
variation in a single region of the restriction factor APOBEC3G
changes specificity for the interaction with the lentiviral Vif protein
[33]. When lentiviruses have adapted to changes in the host
through alternate binding modes, amino acid deletions (and
theoretically alterations in protein structure) were the driving force
behind these adaptations. For example, Vif has shifted its
recognition of APOBEC3G by three to 15 amino acids in a
specific subset of lentiviruses infecting the Colobinae subfamily of
Old World Monkeys, presumably due to a deletion in APO-
BEC3G upstream of the binding site [34]. Additionally, while Nef
recognizes the restriction factor BST-2/tetherin in most primates,
the Nef binding site in BST-2/tetherin is missing in humans [35].
Instead of merely shifting the region of BST-2/tetherin that Nef
binds, HIV-1 adapted a different protein, Vpu, to target and
degrade BST-2/tetherin. In contrast, the results shown here
illustrate the extent to which a novel interface can evolve in the
absence of gross changes in the sequence of the host protein under
attack.
Evolution of Vpx/Vpr and SAMHD1
Changes in Vpx also accompany changes in SAMHD1
recognition. We found that SIVrcm Vpx does not require the
same amino acids to target SAMHD1 as HIV-2/SIVmac Vpx.
However, this is not specific to N-terminal binding Vpx proteins,
as SIVmnd2 Vpx utilizes the same residues as HIV-2/SIVmac
Vpx. How SIVmnd2 Vpx is able to bind to the N-terminus of
SAMHD1 while using the same residues as C-terminally binding
Vpx proteins will need to be determined. Furthermore, whether
SIVmnd2 Vpx or SIVrcm Vpx is the outlier within N-terminally
binding Vpx proteins is still unclear, as more N-terminal binding
Vpx and Vpr proteins will need to be analyzed for their binding to
SAMHD1.
Our results further help to explain the evolutionary signatures
observed in SAMHD1.We had previously reported that most of the
residues in SAMHD1 that show strong signatures of positive
selection in Old World Monkeys were located in the N-terminal
SAM domain, and through altering the amino acids evolving under
positive selection, we functionally showed the SAM domain as an
cells were transfected with HA-SAMHD1, either WT or DC (left panel), or WT or chimeric Human-Rhesus SAMHD1 (consisting of residues 1–114 of
human SAMHD1 and 115–626 of rhesus SAMHD1, right panels), plus or minus FLAG-Vpr, and degradation was measured by western blotting as
described in the legend for Figure 1. Rhesus SAMHD1 was used as all Vpr tested herein can degrade this SAMHD1. Human SAMHD1 was used in N-
terminal chimeras as it contains multiple non-synonymous changes compared to other primate SAMHD1. (B) In vitro ubiquitylation of WT, DC, DN,
and DN/DC DeBrazza’s SAMHD1 (consisting of amino acids 115–595, schematic representation in top panels), in the presence or absence of SIVdeb
Vpr, SIVmac Vpx, or SIVrcm Vpx. CRL4 and CRL4-DCAF1 alone were used as controls. Experiment preformed as in Figure 4B and ubiquitylation of each
SAMHD1 construct was analyzed by western blotting. Timepoints shown are 0, 15, 30, and 60 minute incubations. (C) Schematic Vpx/Vpr
phylogenetic tree as in Figure 1A and SAMHD1 diagrams depicting dependence of Vpx/Vpr on the N- or C-terminus of its autologous SAMHD1. Red
indicates strong dependence based on all assays. Light pink indicates slight dependence based on co-IP data. Magenta indicates intermediate
dependence.
doi:10.1371/journal.ppat.1003496.g006
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important interface in this virus-host antagonism [21]. Another
group, analyzing a wider range of primate species, observed several
sites in the C-terminus of SAMHD1 evolving under positive
selection, and this region was further shown to be necessary for
degradation by Vpx [10,27,28]. Taken together, these results argue
that SAMHD1 has faced selective pressure at both the N and C-
terminus, with possibly a more recent selective pressure on the N-
terminus. Our results in this study indicate that evolution at both of
these surfaces could have been driven by lentiviral Vpx/Vpr,
highlighting the strong selective pressure that lentiviruses impose on
primate evolution. Moreover, our results suggest that adaptive
changes in SAMHD1 have been partially responsible for driving the
changes in Vpx/Vpr that permit toggling of the region of SAMHD1
that is recognized. Together, our data not only fortifies the
importance of the Vpx/Vpr-SAMHD1 interface in the evolution-
ary history of lentiviral interactions with Old World monkeys, but it
further highlights the evolutionary plasticity of an interface between
restriction factors and their lentiviral antagonists.
Methods
Plasmids
SAMHD1, Vpx, and Vpr primary sequences, as well as LPCX-
HA SAMHD1 and pCDNA-3xFLAG Vpx or Vpr constructs were
described previously [21]. SIVsyk Vpr was cloned from the
proviral plasmid [36]. SAMHD1 DC, DN, and chimeric constructs
were generated by PCR and subcloned into LPCX or pCG vector
[8], using standard cloning techniques. Vpx mutants were
generated using Quickchange site-directed mutagenesis PCR
(Stratagene). The following genes were codon-optimized and
synthesized (Genscript): HIV-2 Vpx n019015, n012055, n012002,
n004008, n012034, and SIVsm SL2 Vpx.
Figure 7. Model of Vpx/Vpr toggling specificity for SAMHD1 during the evolutionary arms-race of this virus-host interaction. (A) An
N-terminal binding Vpx shows strong affinity for the N-terminus of SAMHD1, and weak affinity for the C-terminus of another molecule present in the
SAMHD1 tetramer (red and grey arrows, respectively, tetramer is represented as a dimer for simplicity). Vpx/Vpr is represented by a green shape in all
panels. (B) Evolutionary pressure by Vpx alters SAMHD1 sequence at the binding interface, resulting in weakened affinity of Vpx for both the N- and
the C-terminus. This leads to subsequent SAMHD1 escape. (C) A variant of Vpx re-establishes interaction with SAMHD1 either through high affinity for
the N- or the C-terminus, and with weak affinity for the opposite terminus of SAMHD1 in this tetramer. This stabilizes the interaction and leads to
degradation of SAMHD1. Downward dotted arrows represent future antagonism and evolution. Together, the differential affinity of Vpx for disparate
termini in SAMHD1 results in the evolutionary toggling of Vpx/Vpr specificity observed for SAMHD1. This model does not imply a temporal order of
N- or C-terminal binding.
doi:10.1371/journal.ppat.1003496.g007
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Transfection
Transfection in 293T cells was performed as described [21] with
minor modifications. Briefly, cells were transfected with 200 ng of
LPCX-HA-SAMHD1 with or without 100 ng of Vpx/Vpr
constructs using TransIT-LT1 (Mirus Bio). Codon optimized
Vpx/Vpr was titrated in order to normalize for similar levels of
protein expression. The total amount of DNA in all transfections
was maintained constant with appropriate empty vectors. Thirty-
six hours post-transfection, cells were harvested for Western blot
analysis.
Immunoprecipitations and Western blotting
Immunoprecipitations were performed as described previously
[8,10]. For whole cell lysates, 293T cells were lysed in RIPA buffer
for 10 minutes on ice, and spun at 15,000 g for 10 minutes to
pellet. Lysates were run on NuPAGE Novex 4–12% Bis-Tris
gradient gels (Invitrogen). The following antibodies were used:
HA-specific antibody (Babco), anti-FLAG M2 antibody (Sigma-
Aldrich), anti-tubulin (Sigma-Aldrich), anti-DDB1 (Invitrogen);
DCAF1 was detected with rabbit antibody raised to recombinant
protein [37]. Primary antibodies were detected with a correspond-
ing horseradish peroxidase-conjugated secondary antibody (Santa
Cruz Biotech).
Phylogenetic analysis
Phylogenetic trees were constructed from amino acid align-
ments of Vpx sequences obtained from the Los Alamos HIV
sequence database [38]. Alignments were performed using fast
statistical alignment (FSA) [39] or Muscle [40]. Phylogenies were
constructed with PhyML [41] by the maximum-likelihood (ML)
method. Support for ML trees was assessed by aLRT [42].
Analyses were performed at least three times.
In vitro SAMHD1 recruitment assays
Recombinant Rhesus SAMHD1 including full-length (WT), 1–
595 (SAMHD1-DC) and 113–625 (DN-SAMHD1) and human
DDB1-DCAF1c (1045–1396), and DDB1-DCAF1c in complex
with viral accessory proteins, including Vpx (SIVmac) and Vpx
(RCM) were expressed and purified as described previously [10].
Typically, 100 mL of protein mixtures as indicated were injected
into an analytical size exclusion column (Superdex200,
106250 mm, 24 mL) equilibrated with a buffer containing
25 mM sodium phosphate, pH 7.5, 150 mM NaCl, 5% glycerol,
and 0.02% azide at a flow rate of 0.8 mL/min. The peak fractions
(0.5 mL) were concentrated to 20-fold and analyzed by SDS-
PAGE. The gel was first developed with Coomassie Blue stain, and
subsequently Silver stained.
In vitro ubiquitylation assays
In vitro ubiquitylation was performed as previously described
[10]. Briefly, E1 (UBA1, 0.2 mM), E2 (UbcH5b, 2.5 mM), and E3
complexes (mixtures of DDB1-DCAF1c-Vpx and CUL4A-RBX1
at 0.3 mM, indicated as CRL4-DCAF1-Vpx) were typically
incubated with 0.6 mM of T7-tagged SAMHD1 and 2.5 mM of
His6-FLAG-tagged ubiquitin in a buffer containing 10 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 5% Glycerol, 20 U/mL pyrophos-
phatase, 2 mM DTT and 5 mM ATP at 37uC for 0, 15 and
30 min. The reaction was quenched with non-reducing SDS-
PAGE gel loading buffer and analyzed by Western blotting.
Supporting Information
Figure S1 Phylogenetic analysis of HIV-2 and SIVsm
Vpx proteins, related to Figure 1. (A) Alignment of HIV-2
and SIVsmm Vpx protein sequences was performed with FSA,
and the maximum likelihood tree was generated with PhyML.
aLRT values greater than 0.75 are shown at key nodes and
denoted with a *. HIV-2 and SIVsmm sample names are shown
and the Vpx proteins tested in (B) are highlighted in bold. (B) 293T
cells were transfected with human HA-SAMHD1, either WT or
DC, plus or minus FLAG-Vpx from HIV-2 or SIVsmm, and
degradation was measured by western blotting.
(PDF)
Figure S2 Amino acid diversity of SAMHD1 in the N-
and C-terminus, related to Figure 2. Alignments of N-
termini and C-termini of SAMHD1 proteins analyzed in this
study. SAMHD1 protein alignments were performed with Muscle
[40]. Dashed line indicates conserved amino acid.
(PDF)
Figure S3 N- and C-terminal binding Vpx proteins
recruit SAMHD1 to the DDB1-DCAF1 complex through
a conserved mechanism, related to Figure 4. In vitro rhesus
SAMHD1 recruitment assays with SIVmac or SIVrcm Vpx. (A)
100 mL of SAMHD1-FL (a), SAMHD1-DC (b), and DN-
SAMHD1 (c) at 1.5 mM were injected into an analytical Superdex
200 size exclusion column (106250 mm, 24 mL), equilibrated
with a buffer containing a 25 mM sodium phosphate, pH 7.5,
150 mM NaCl, 5% glycerol, and 0.02% azide at a flow rate of
0.8 mL/minA. Trace of UV280 nm with elution volume of the
peak is shown. Chromatograms are shown at top, labeled a–c, and
fractions analyzed by Coomassie stain, shown below, are
numbered (1–3, corresponding to the peak elution). (B) DDB1-
DCAF1c in complex with SIVmac Vpx (a, 1), without Vpx (b, 2),
or with SIVrcm Vpx (c, 3) at a concentration of 3.5 mM were
analyzed as described in A. Silver staining of the lower molecular
weight region of SDS-PAGE gel is shown for visualization of Vpx.
(C) Mixtures of DDB1-DCAF1c (3.5 mM) with FL (a, 1–4), DC (b,
5–7), and DN (c, 8–10) SAMHD1 at 1.5 mM were analyzed as
described in A. (D) Mixtures of DDB1-DCAF1c-SIVmac Vpx
(3.5 mM) with FL (a, 1–7), DC (b, 8–10), and DN (c, 11–15)
SAMHD1 (1.5 mM) were analyzed as in (A); (E) DDB1-DCAF1c-
SIVrcm Vpx (3.5 mM) with FL (a, 1–7), DC (b, 8–15), and DN (c,
16–17) SAMHD1(1.5 mM) were also analyzed as in (A).
(PDF)
Figure S4 Mutations in SIVrcm Vpx that do not abolish
degradation of SAMHD1 do not change breadth or
requirement for SAMHD1 N- or C-terminus, related to
Figure 5. Mutant SIVrcm 12 HIV-2 17 Vpx was tested for the gain
of function, loss of function, or altered dependence on the N- or C-
terminus to degrade SAMHD1. 293T cells were co-transfected
with (+) or without (2) FLAG-Vpx and HA-tagged Human-RCM
SAMHD1 chimeras (Hu-RCM) for gain of function, RCM-
Human SAMHD1 chimeras (RCM-Hu) for loss of function, or C-
terminally truncated SAMHD1 chimeras (Hu-RCM DC and
RCM-Hu DC) for altered dependence on the N- or C-terminus,
and analyzed by western blotting.
(PDF)
Figure S5 SIVagm.gri Vpr shows a dependence on both
the N- and the C-terminus of SAMHD1. HA-tagged AGM
SAMHD1 (WT, DC, and DN) were transiently co-expressed in
293T cells with FLAG-SIVagm.gri Vpr (Vpr from SIV that infects
the AGM grivet subspecies) and immunoprecipitated from whole
cell extracts with anti-HA resin. HA-SAMHD1, FLAG-Vpr,
DCAF, and DDB1 were detected in immune complexes (upper
panels) or extracts (lower panels) by western blotting.
(PDF)
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